Cognitive and Neuropsychiatric Screening Tests in Older Adults

Abstract

A number of instruments are available to clinicians to assess cognitive and neuropsychiatric features of neurocognitive disorders in older adults, from preclinical and prodromal stages through to more severe stages of dementia. This chapter provides a comprehensive overview and discussion of the key characteristics to consider when selecting a screening instrument to support accurate and timely assessment of cognitive changes and neuropsychiatric symptoms, both of which are core features of neurocognitive disorders. Particular consideration must be given to factors such as the assessment setting (e.g., acute care versus residential care environment), the population for which a measure was developed, and the context in which the instrument was validated. When selecting an instrument, clinicians must also consider possible population-based bias effects as a result of use in culturally and linguistically diverse populations or due to differences in educational attainment. Improving understanding of the diversity in measures available to assist clinicians in differing care contexts is fundamental so that the best possible care and treatment plans can be implemented, and better support provided to next of kin and caregivers (both formal and informal caregivers). (PsycInfo Database Record (c) 2022 APA, all rights reserved)